Phenotype of asthma-chronic obstructive pulmonary disease overlap syndrome
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Many patients with asthma or chronic obstructive pulmonary disease (COPD) have overlapping characteristics of both diseases. By spirometric definition, patients with both fixed airflow obstruction (AO) and bronchodilator reversibility or fixed AO and bronchial hyperresponsiveness can be considered to have asthma- COPD overlap syndrome (ACOS). However, patients regarded to have ACOS by spirometric criteria alone are heterogeneous and can be classified by phenotype. Eosinophilic inflammation, a history of allergic disease, and smoke exposure are important components in the classification of ACOS. Each phenotype has a different underlying pathophysiology, set of characteristics, and prognosis. Medical treatment for ACOS should be tailored according to phenotype. A narrower definition of ACOS that includes both spirometric and clinical criteria is needed.
Abstract
Many patients with asthma or chronic obstructive pulmonary disease (COPD) have overlapping characteristics of both diseases. By spirometric definition, patients with both fixed airflow obstruction (AO) and bronchodilator reversibility or fixed AO and bronchial hyperresponsiveness can be considered to have asthma- COPD overlap syndrome (ACOS). However, patients regarded to have ACOS by spirometric criteria alone are heterogeneous and can be classified by phenotype. Eosinophilic inflammation, a history of allergic disease, and smoke exposure are important components in the classification of ACOS. Each phenotype has a different underlying pathophysiology, set of characteristics, and prognosis. Medical treatment for ACOS should be tailored according to phenotype. A narrower definition of ACOS that includes both spirometric and clinical criteria is needed.
참고문헌 (33)
- Gibson PG, "The overlap syndrome of asthma and COPD: what are its features and how important is it?", Thorax, 64, pp.728~735 (2009)
- Lange P, "A 15-year follow-up study of ventilatory function in adults with asthma", N Engl J Med, 339, pp.1194~1200 (1998)
- James AL, "Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking", Am J Respir Crit C are Med, 171, pp.109~114 (2005)
- Thomsen M, "Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study", Lancet Respir Med, 1, pp.543~550 (2013)
- Ulrik CS, "Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma", Eur Respir J, 14, pp.892~896 (1999)
- Tai A, "The association between childhood asthma and adult chronic obstructive pulmonary disease", Thorax, 69, pp.805~810 (2014)
- Covar RA, "Childhood Asthma Management Program Research Group. Progression of asthma measured by lung function in the childhood asthma management program", Am J Respir Crit Care Med, 170, pp.234~241 (2004)
- Martinez FD, "Diminished lung function as a predisposing factor for wheezing respiratory illness in infants", N Engl J Med, 319, pp.1112~1117 (1988)
- 이희원, "Clinical Characteristics of Asthma Combined with COPD Feature", Yonsei Medical Journal, 55(4), pp.980~986 (2014), 연세대학교의과대학[DOI]
- Lee JH, "Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study", Chest, 132, pp.1882~1889 (2007)
- Perret JL, "The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age", Am J Respir Crit Care Med, 187, pp.42~48 (2013)
- Jamieson DB, "Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 188, pp.187~192 (2013)
- Moerloose KB, "Short-term cigarette smoke exposure enhances allergic airway inflammation in mice", Am J Respir Crit Care Med, 172, pp.168~172 (2005)
- Iwamoto H, "Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap", Eur Respir J, 43, pp.421~429 (2014)
- Kitaguchi Y, "Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma", Int J Chron Obstruct Pulmon Dis, 7, pp.283~289 (2012)
- Hardin M, "The clinical features of the overlap between COPD and asthma", Respir Res, 12, pp.127~ (2011)
- Menezes AM, "Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma", Chest, 145, pp.297~304 (2014)
- Rhee CK, "Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma", COPD, 11, pp.163~170 (2014)
- Diaz-Guzman E, "Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population", COPD, 8, pp.400~407 (2011)
- Tashkin DP, "Bronchodilator responsiveness in patients with COPD", Eur Respir J, 31, pp.742~750 (2008)
- Vestbo J, "Changes in forced expiratory volume in 1 second over time in COPD", N Engl J Med, 365, pp.1184~1192 (2011)
- Tashkin DP, "Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease: The Lung Health Study Research Group", Am J Respir Crit Care Med, 153(6 Pt 1), pp.1802~1811 (1996)
- Peters SP, "Tiotropium bromide step-up therapy for adults with uncontrolled asthma", N Engl J Med, 363, pp.1715~1726 (2010)
- Kerstjens HA, "Tiotropium in asthma poorly controlled with standard combination therapy", N Engl J Med, 367, pp.1198~1207 (2012)
- Iwamoto H, "Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype", Eur Respir J, 31, pp.1379~1380 (2008)
- Simpson JL, "Clarithromycin targets neutrophilic airway inflammation in refractory asthma", Am J Respir Crit Care Med, 177, pp.148~155 (2008)
- Brusselle GG, "Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial", Thorax, 68, pp.322~329 (2013)
- Price D, "Effect of montelukast for treatment of asthma in cigarette smokers", J Allergy Clin Immunol, 131, pp.763~771 (2013)
- Celli BR, "Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study", Am J Respir Crit Care Med, 178, pp.332~338 (2008)
- Decramer M, "Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial", Lancet, 374, pp.1171~1178 (2009)
- Albert RK, "Azithromycin for prevention of exacerbations of COPD", N Engl J Med, 365, pp.689~698 (2011)
- Uzun S, "Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial", Lancet Respir Med, 2, pp.361~368 (2014)
- Soler-Cataluna JJ, "Consensus document on the overlap phenotype COPD-asthma in COPD", Arch Bronconeumol, 48, pp.331~337 (2012)